ADAGE CAPITAL PARTNERS GP, L.L.C. - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 168 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
ADAGE CAPITAL PARTNERS GP, L.L.C. ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$4,546,000
-47.2%
350,110
-43.8%
0.01%
-52.6%
Q4 2020$8,618,000
-6.1%
623,1100.0%0.02%
-17.4%
Q3 2020$9,178,000
+41.2%
623,110
+55.8%
0.02%
+35.3%
Q2 2020$6,500,000
+12.0%
400,0000.0%0.02%0.0%
Q1 2020$5,804,000400,0000.02%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders